TY - JOUR T1 - Good communication is critical to supporting people living and working with a rare disease: current rare disease support perceived as inadequate JF - medRxiv DO - 10.1101/2020.05.22.20110056 SP - 2020.05.22.20110056 AU - Julie McMullan AU - Ashleen L. Crowe AU - Caitlin Bailie AU - Kerry Moore AU - Lauren S. McMullan AU - Nahid Shamandi AU - Helen McAneney AU - Amy Jayne McKnight Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/25/2020.05.22.20110056.abstract N2 - Background Many people living and working with rare diseases describe consistent difficulties accessing appropriate information and support. In this study an evaluation of the awareness of rare diseases, alongside related information and educational resources available for patients, their families and healthcare professionals, was conducted in 2018-2019 using an online survey and semi-structured interviews with rare disease collaborative groups (charities, voluntary and community groups) active across Northern Ireland (NI).Results Ninety-nine participants engaged with the survey with 31 respondents providing detailed answers. Resources such as information, communication, ‘registries’, online services, training and improvements to support services were queried. Excellent communication is an important factor in delivering good rare disease support. Training for health professionals was also highlighted as an essential element of improving support for those with a rare disease to ensure they approach people with these unique and challenging diseases in an appropriate way. Carers were mentioned several times throughout the study; it is often felt they are overlooked in rare disease research and more support should be in place for them. Current care/support for those with a rare disease was highlighted as inadequate. Nine semi-structured interviews were conducted with rare disease collaborative groups. Reoccurring themes included a need for more effective: information and communication, training for health professionals, online presence, support for carers, and involvement in research.Conclusions All rare disease collaborative groups agreed that current services for people living and working with a rare disease are not adequate. An important finding to consider in future research within the rare disease field is the inclusion of carers perceptions and experiences in studies. Due to the unique role a carer has in the life of a person with a rare disease it is vital that their voice is heard and their needs are listened to. This research provides insight into the support available for rare diseases across Northern Ireland, highlights unmet needs in service provision, and suggests approaches to improve rare disease support prioritising improved information and communication provision, improved access to services, and tailored support for carers of people with a rare disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJM was supported by an award from the NI Public Health Agency and the Medical Research Council Northern Ireland Executive support of the Northern Ireland Genomic Medicine Centre though Belfast Health and Social Care Trust. AC and CB are recipients of PhD studentships from the Department for the Economy NI. KM is supported by an award from the Rank Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has ethical approval from QUBs School of Medicine, Dentistry and Biomedical Sciences research ethics committee, Northern Ireland. Consent to take part in the survey was explicitly given by all participants by actively ticking a consent box before they could proceed with the online survey. Consent for the interviews was collected via a hard copy form which was signed by the participant.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and/or analysed during the current study are not publicly available due as they contain potentially identifiable information but are available from the corresponding author on reasonable request ER -